BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9184705)

  • 1. Efficacy and safety of intravenous phosphate replacement in critically ill patients.
    Perreault MM; Ostrop NJ; Tierney MG
    Ann Pharmacother; 1997 Jun; 31(6):683-8. PubMed ID: 9184705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous phosphate in the intensive care unit: more aggressive repletion regimens for moderate and severe hypophosphatemia.
    Charron T; Bernard F; Skrobik Y; Simoneau N; Gagnon N; Leblanc M
    Intensive Care Med; 2003 Aug; 29(8):1273-8. PubMed ID: 12845429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous phosphate repletion regimen for critically ill patients with moderate hypophosphatemia.
    Rosen GH; Boullata JI; O'Rangers EA; Enow NB; Shin B
    Crit Care Med; 1995 Jul; 23(7):1204-10. PubMed ID: 7600828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new graduated dosing regimen for phosphorus replacement in patients receiving nutrition support.
    Brown KA; Dickerson RN; Morgan LM; Alexander KH; Minard G; Brown RO
    JPEN J Parenter Enteral Nutr; 2006; 30(3):209-14. PubMed ID: 16639067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous repletion of phosphorus deficiency in the chronic renal failure patients with severe hypophosphatemia.
    Chang JM; Tsai JC; Hwang SJ; Chen HC; Guh JY; Lai YH
    Kaohsiung J Med Sci; 1997 Sep; 13(9):540-7. PubMed ID: 9348731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refeeding syndrome: effective and safe treatment with Phosphates Polyfusor.
    Terlevich A; Hearing SD; Woltersdorf WW; Smyth C; Reid D; McCullagh E; Day A; Probert CS
    Aliment Pharmacol Ther; 2003 May; 17(10):1325-9. PubMed ID: 12755846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnesium repletion and its effect on potassium homeostasis in critically ill adults: results of a double-blind, randomized, controlled trial.
    Hamill-Ruth RJ; McGory R
    Crit Care Med; 1996 Jan; 24(1):38-45. PubMed ID: 8565536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic aspects of phosphate replacement therapy for hypophosphatemia after renal transplantation: impact on muscular phosphate content, mineral metabolism, and acid/base homeostasis.
    Ambühl PM; Meier D; Wolf B; Dydak U; Boesiger P; Binswanger U
    Am J Kidney Dis; 1999 Nov; 34(5):875-83. PubMed ID: 10561144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypophosphatemia and phosphate supplementation during continuous renal replacement therapy in children.
    Santiago MJ; López-Herce J; Urbano J; Bellón JM; del Castillo J; Carrillo A
    Kidney Int; 2009 Feb; 75(3):312-6. PubMed ID: 19002217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potassium and phosphorus repletion in hospitalized patients: implications for clinical practice and the potential use of healthcare information technology to improve prescribing and patient safety.
    Hemstreet BA; Stolpman N; Badesch DB; May SK; McCollum M
    Curr Med Res Opin; 2006 Dec; 22(12):2449-55. PubMed ID: 17257459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of hypophosphatemia in patients receiving specialized nutrition support using a graduated dosing scheme: results from a prospective clinical trial.
    Clark CL; Sacks GS; Dickerson RN; Kudsk KA; Brown RO
    Crit Care Med; 1995 Sep; 23(9):1504-11. PubMed ID: 7664552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphate addition to hemodiafiltration solutions during continuous renal replacement therapy.
    Troyanov S; Geadah D; Ghannoum M; Cardinal J; Leblanc M
    Intensive Care Med; 2004 Aug; 30(8):1662-5. PubMed ID: 15156308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of potassium infusion therapy in hypokalemic critically ill patients.
    Hamill RJ; Robinson LM; Wexler HR; Moote C
    Crit Care Med; 1991 May; 19(5):694-9. PubMed ID: 2026032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Randomized Noninferiority Trial to Compare Enteral to Parenteral Phosphate Replacement on Biochemistry, Waste, and Environmental Impact and Healthcare Cost in Critically Ill Patients With Mild to Moderate Hypophosphatemia.
    Nguyen CD; Panganiban HP; Fazio T; Karahalios A; Ankravs MJ; MacIsaac CM; Rechnitzer T; Arno L; Tran-Duy A; McAlister S; Ali Abdelhamid Y; Deane AM
    Crit Care Med; 2024 Jul; 52(7):1054-1064. PubMed ID: 38537225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of intravenous phosphorus therapy in the severely hypophosphatemic patient.
    Vannatta JB; Whang R; Papper S
    Arch Intern Med; 1981 Jun; 141(7):885-7. PubMed ID: 7235807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypophosphatemia in critically ill patients.
    Suzuki S; Egi M; Schneider AG; Bellomo R; Hart GK; Hegarty C
    J Crit Care; 2013 Aug; 28(4):536.e9-19. PubMed ID: 23265292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypophosphatemia: an evidence-based problem-solving approach to clinical cases.
    Assadi F
    Iran J Kidney Dis; 2010 Jul; 4(3):195-201. PubMed ID: 20622306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of hypophosphatemia using a protocol based on patient weight and serum phosphorus level in a surgical intensive care unit.
    Taylor BE; Huey WY; Buchman TG; Boyle WA; Coopersmith CM
    J Am Coll Surg; 2004 Feb; 198(2):198-204. PubMed ID: 14759775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hypophosphatemia in the hospitalized patient].
    Chermesh I; Meshulam C; Tamir A; Eliakim R; Levy Y
    Harefuah; 2006 Nov; 145(11):786-8, 864. PubMed ID: 17183945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study on safety and efficacy of concentrated potassium chloride infusions in critically ill patients with hypokalemia].
    He Q; Wang JH; Liu YL; Tang PX; Chang ZG; Du LQ; Huang XF
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2008 Jul; 20(7):416-8. PubMed ID: 18611341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.